Rumblings in toy land
First comes news that Dexcom and Verily, Google’s life sciences unit, have amended their partnership agreement. A move we attributed more towards Google being unclear on where they are going then Dexcom not wanting Google as a partner. Partnerships in business like life relationships go through their ups and downs. Therefore, we weren’t that surprised when Dexcom announced they were raising more money. Per a press release; “DexCom, Inc. (DXCM) (“DexCom”) announced...
Cyber Monday
Now that we live in the interconnected age, we can add some new traditions to our old ones – in the past the Friday after Thanksgiving was and still is known as Black Friday – now in the internet age we can add Cyber Monday to our holiday shopping experience. Yet shopping isn’t the only thing we have on our mind this Cyber Monday check out a few news items...
Change in the Valley
By now everyone has likely seen the press release issued by Dexcom announcing they have amended their agreement with Verily Google’s life sciences unit. Per that release; “DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), and Verily, an Alphabet company, announced an amendment to the Collaboration and License Agreement surrounding the ongoing development efforts between the companies. The revised terms are intended to reinforce the companies’ mutual product development...
Scale + Churn = Revenue Growth
When it comes to the real estate market the most important factor is location. When it comes to the insulin pump market it’s all about scale. And scale is something Medtronic has in abundance. However, this huge scale is also somewhat misleading, and the results released by Medtronic this morning are a perfect example of just how misleading scale can be. This morning the company reported “Diabetes Group worldwide second quarter...
Not seeing too well
Since Momma Kliff told us never to gloat we won’t take too much credit for once again being right. Last week Verily, Google’s life sciences unit, halted development of their way cool whiz bang contact lenses which were supposed to measure glucose levels. Per a post on the CNBC website; “But in a blog post on Friday, Verily said that after four years of research it has determined that detecting blood...
A Closer Look
Sometimes when something doesn’t make sense you can either scratch your head or take a closer to look to see if you perhaps missed something. We mention this as we just couldn’t understand why Novo Nordisk was studying the oral version of semaglutide to death. Why they weren’t aggressively getting this drug to the FDA. At first, we chalked up this lackadaisical attitude to Novo being Novo. A company that based...
This will not go away
While we’re not quite sure if its required by law it seems as though every insulin pump wannabe must not just say how way cool whiz bang their toy is but also how they will do what has never been done before and get insulin using Type 2 patients on a pump. Now keep in mind only 35% of Type 1 patients, patients who must be on insulin, use an...
Just what is Google up to?
First Google poaches a top flight executive to head up their move into health. Next they announce per a post on FireceBioTech; “DeepMind, Alphabet’s U.K.-based artificial intelligence company, announced in a blog post that the team responsible for its Streams app and medical research projects will be joining the tech giant. Google first acquired DeepMind in 2014, before restructuring into its parent company, Alphabet, and transferring its subsidiaries.” Already the company is...
Diabetes Day
Now that the midterm elections are over, well almost over and not to digress but it seems to us that if we can have a hybrid closed loop insulin delivery system shouldn’t the state of Florida be able to count votes, just saying. Anyway no matter which way a person leans politically it’s obvious that healthcare was a big issue when people hit the voting booth. An issues which will...
A Bakers Dozen
By our count there are at least 12 companies that either have or are working on a “smart” insulin pen and these do not include the efforts underway at Novo Nordisk or Lilly. While most are what we would call Cap Covers that attach to a disposable insulin pen, there are some like the Companion InPen which are stand-alone units. Nearly every one of these whiz bang way cool cloud...